Format

Send to

Choose Destination
Oxid Med Cell Longev. 2013;2013:963217. doi: 10.1155/2013/963217. Epub 2013 Dec 29.

Resveratrol: why is it a promising therapy for chronic kidney disease patients?

Author information

1
Graduate Program in Medical Sciences, Federal Fluminense University (UFF), Niteroi, RJ, Brazil.
2
Clinical Nutrition Department, State University of Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
3
Department of Renal Medicine K56, Huddinge University Hospital, Karolinska Institutet, 141 86 Stockholm, Sweden.
4
University Hospital Antonio Pedro, Medicine Faculty of Federal Fluminense University (UFF), Niteroi, RJ, Brazil.

Abstract

Resveratrol, a phenolic compound found in various plants, including grapes, berries, and peanuts, shows promise for the treatment of cancer, aging, type 2 diabetes, and cardiovascular diseases. Resveratrol can promote transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2) activation, increase the expression level of SIRT-1, which is a sirtuin family protein, and reduce mTOR pathway signaling. This compound has anti-inflammatory properties in that it inhibits or antagonizes the nuclear factor-κB (NF-κB) activity, which is a redox-sensitive transcription factor that coordinates the inflammatory response. Inflammation and oxidative stress, which are common features in patients with chronic kidney disease (CKD), are interrelated and associated with cardiovascular disease and the progression of CKD itself. Because of the modulation of the mechanisms involved in the inflammatory-oxidative stress cycle, resveratrol could play an important role in controlling CKD-related metabolic derangements. Although resveratrol supplementation in theory is a promising therapy in this patient group, there are no studies evaluating its effects. Thus, the present review aims to describe the role of resveratrol in inflammation and oxidative stress modulation and its possible benefits to patients with CKD.

PMID:
24489988
PMCID:
PMC3893857
DOI:
10.1155/2013/963217
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center